Logo image of CHSCM

CHS INC - CHSINC 6 3/4 PERP (CHSCM) Stock Fundamental Analysis

NASDAQ:CHSCM - Nasdaq - US12542R7044

25.1301  -0.08 (-0.32%)

Fundamental Rating

4

Taking everything into account, CHSCM scores 4 out of 10 in our fundamental rating. CHSCM was compared to 91 industry peers in the Food Products industry. CHSCM has only an average score on both its financial health and profitability. CHSCM has a expensive valuation and it also scores bad on growth. CHSCM also has an excellent dividend rating. This makes CHSCM very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHSCM had a positive cash flow from operations.
Each year in the past 5 years CHSCM has been profitable.
Each year in the past 5 years CHSCM had a positive operating cash flow.
CHSCM Yearly Net Income VS EBIT VS OCF VS FCFCHSCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

The Return On Assets of CHSCM (7.92%) is better than 84.88% of its industry peers.
With a decent Return On Equity value of 14.11%, CHSCM is doing good in the industry, outperforming 75.58% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.88%, CHSCM is in the better half of the industry, outperforming 60.47% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHSCM is below the industry average of 9.02%.
The 3 year average ROIC (5.40%) for CHSCM is below the current ROIC(5.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCM Yearly ROA, ROE, ROICCHSCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

CHSCM's Profit Margin of 3.62% is in line compared to the rest of the industry. CHSCM outperforms 55.81% of its industry peers.
CHSCM's Profit Margin has improved in the last couple of years.
CHSCM has a Operating Margin (2.42%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CHSCM has grown nicely.
CHSCM has a worse Gross Margin (5.06%) than 82.56% of its industry peers.
CHSCM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCM Yearly Profit, Operating, Gross MarginsCHSCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCM is creating some value.
The debt/assets ratio for CHSCM has been reduced compared to a year ago.
CHSCM Yearly Shares OutstandingCHSCM Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCM Yearly Total Debt VS Total AssetsCHSCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

CHSCM has an Altman-Z score of 2.82. This is not the best score and indicates that CHSCM is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCM has a better Altman-Z score (2.82) than 61.63% of its industry peers.
The Debt to FCF ratio of CHSCM is 1.02, which is an excellent value as it means it would take CHSCM, only 1.02 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.02, CHSCM belongs to the top of the industry, outperforming 86.05% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHSCM is not too dependend on debt financing.
The Debt to Equity ratio of CHSCM (0.19) is better than 68.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.02
WACC5.76%
CHSCM Yearly LT Debt VS Equity VS FCFCHSCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCM has a Current Ratio of 1.58. This is a normal value and indicates that CHSCM is financially healthy and should not expect problems in meeting its short term obligations.
CHSCM has a Current ratio of 1.58. This is comparable to the rest of the industry: CHSCM outperforms 53.49% of its industry peers.
CHSCM has a Quick Ratio of 1.58. This is a bad value and indicates that CHSCM is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCM has a Quick ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCM Yearly Current Assets VS Current LiabilitesCHSCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

CHSCM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.09%.
Measured over the past years, CHSCM shows a small growth in Revenue. The Revenue has been growing by 6.88% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCM Yearly Revenue VS EstimatesCHSCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B
CHSCM Yearly EPS VS EstimatesCHSCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCM Price Earnings VS Forward Price EarningsCHSCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

97.67% of the companies in the same industry are more expensive than CHSCM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CHSCM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.96
CHSCM Per share dataCHSCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

The decent profitability rating of CHSCM may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

CHSCM has a Yearly Dividend Yield of 7.00%, which is a nice return.
CHSCM's Dividend Yield is rather good when compared to the industry average which is at 3.86. CHSCM pays more dividend than 93.02% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, CHSCM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7%

5.2 History

The dividend of CHSCM has a limited annual growth rate of 0.78%.
CHSCM has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.78%
Div Incr Years0
Div Non Decr Years2
CHSCM Yearly Dividends per shareCHSCM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

CHSCM pays out 11.11% of its income as dividend. This is a sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCM Yearly Income VS Free CF VS DividendCHSCM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCM Dividend Payout.CHSCM Dividend Payout, showing the Payout Ratio.CHSCM Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 6 3/4 PERP

NASDAQ:CHSCM (1/22/2025, 10:23:54 AM)

25.1301

-0.08 (-0.32%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-08 2025-01-08
Earnings (Next)04-01 2025-04-01
Inst Owners13.8%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner Change0%
Market Cap308.35M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 7%
Yearly Dividend2.04
Dividend Growth(5Y)0.78%
DP11.11%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B 0.03
P/tB 0.03
EV/EBITDA 0.96
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY712.22%
OCF(TTM)233.94
OCFY930.9%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.76%
ROIC/WACC1.02
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%